During embryonic development, and possibly also later in life, pancreatic islets of Langerhans originate from differentiating epithelial stem cells. These stem cells are situated in the pancreatic ducts but are otherwise poorly characterized. K$k bund by immunohistochemical staining that protodifkentiated pancreatic epithelial cells from rat embryos of Dzy 13-Day 15 express the cytoskeletal protein keratin 20, similar to mature duct epithelium. During the period of iskt morphogenesis, which occurs between Day 17 and binh, largeaggregates of K20-positive duct cells were formed, which gradually differentiated into endocrine cells. This islet morphogenic mechanism has not been described thus
Introduction
It is generally accepted that the endocrine islets of Langerhans originate from stem cells located in the pancreatic ducts during ontogeny, and possibly by the same mechanism postnatally (Slack, 1995) . This has generated interest in the possibility of regenerating or expanding insulin-producing cells from their progenitors to restore glucose homeostasis in diabetics (Rosenberg et al., 1990) . However, our present knowledge of islet morphogenesis and islet stem cells is very limited. The islet morphogenic mechanism has been described tentatively as "budding" of endocrine cells from the epithelial lining of ducts (Rutter, 1980; Pictet and Rutter, 1972) . Repeated endocrine cell escape from the duct lining would then lead to accumulation of endocrine cells between the duct and the exocrine acini, i.e., to islet formation. No studies thus far have made use of specific markers for duct cells or epithelial stem cells to follow islet morphogenesis. The present immunohistochemical study was aimed at analyzing islet development in fetal rat pancreas by making use of specific markers for duct, endocrine, and mesenchymal cells. In addition, bcl-2 proto-oncoprotein expression was examined as a marker for epithelial stem cells. far and we did not observe it in postnatal rats. During fetal islet formation, transient expression of vimentin was noted in the duct cells but not in endocrine cells. This intermediate filament protein is not observed in duct epithelial cells after birth. The proto-oncogene product bcl-2, a putative epithelial stem cell marker, was detected in duct cells from fetal and postnatal pancreas. We conclude that K20, vimentin, and bd-2 are markers for the pancreatic (islet) stem 
Materials and Methods
Animals. Timed pregnant Wistar rats were purchased from Proefdierencentrum (Heverlee, Belgium). The day after mating was designated as Day 1 of gestation. Rat fetuses were obtained on gestational Days 13, 15, 17, 19, and 20 (term = Day 22) . Neonatal rats were used at ages 0. 2. and 5 days. Adult rats were 10-12 weeks old. At least three rats were analyzed per investigated time point. Experiments were approved by the local ethical committee and were in compliance with the guidelines of the European Community.
Tissue Processing. Rats were decapitated under narcosis with diethylether.
Whole fetuses or pieces of pancreas were fixed in phosphate-buffered 4% formaldehyde for 4 hr, dehydrated with ethanol, and embedded in paraffin . Paraffin sections 3-4 pm thick were prepared for immunostaining.
Antibodies. We used commercial mouse monoclonal antibodies (MAbs) to keratin 20 (anti-KZO) (clone Ks20.8; Dako, Glostrup, Denmark), vimentin (clone V9; Boehringer, Mannheim, Germany), and bcl-2 (clone 124: Dako). Polyclonal antisera were used to detect insulin and glucagon (courtesy of Dr. C. Van Schravendijk, Brussels. Belgium).
Immunohistochemistry.
To prevent aspecific binding of antibodies, we applied 10% normal goat serum and 0.8% bovine serum albumin (wh) dissolved in PBS [loo-200 pllsection; 30 min at room temperature (RT)]. Endogenous peroxidase activity was blocked with 3Oh hydrogen peroxide in methanol (30 min at RT). The streptavidin-biotin complex (ABC; Dako) immunoperoxidase method was used with diaminobenzidine as chromogen, as described . Secondary (biotinylated) antibodies were obtained from Amersham (Poole, UK). Controls in which the primary antibody was omitted consistently gave completely negative staining.
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Results
Pancreas Formation
The pancreatic rudiment of gestational Day 13 consisted of an apparently unorganized cell mass. The K2O marker for duct cells was detected in all epithelial cells, although with relatively weak staining intensity (Figure la) . On Day 15, duct structures had developed that exhibited intense K2O immunoreactivity ( Figure Ib) . These were surrounded by mesenchymal tissue containing many vimentin-positive cells. The duct lining itself was vimentin-negative (not shown). Primitive acinar structures were seen that did not yet contain zymogen granules and which stained weakly or were negative for K2O ( Figure Ib) . Insulin-positive cells were not detected, but clusters of glucagon-positive cells were present at the ductmesenchymal interface (not shown).
Islet Morphogenesis
After Day 17 of gestation, the pancreas was rapidly expanding and became macroscopically visible on Day 19. On Day 17, relatively few insulin-positive cells were seen and these were scattered as single cells along the duct lining. At the same time, large aggregates of cells appeared that stained intensely for K20 and became most conspicuous on Day 19 (Figure 2a ). These aggregates were significantly larger than exocrine acini and were often seen to comprise several ductules with visible lumens that were connected to exocrine acini. In the middle of these duct aggregates, endocrine cells appeared in clusters of various sizes (Figure 2b ). These hormonepositive cells weakly expressed K20. Interestingly, vimentin immunoreactivity was now present in most duct epithelial cells, with the highest staining intensity on Day 20. Islets were surrounded by a mantle of duct cells co-expressing K20 and vimentin. Endo- ously reported (Bouwens et al., 1994) , but vimentin staining was absent postnatally in all duct epithelium and vimentin was detected only in mesenchymal cells (Figure 4) .
B d 2 Expression
Bcl-2 was first detected on Day 15 in the pancreatic main duct, and thereafter was present in all duct cells. During the period of islet morphogenesis (Days 17-20) we also noted weak immunoreactivity in islet cells (Figure sa) , which disappeared by the time of birth. After birth, bcl-2 was detected only in duct cells (Figure 5b ). It was present in most centroacinar, intralobular, and interlobular duct cells. Bcl-2 immunostaining presented as granular cytoplasmic staining in accordance with its mitochondrial localization (Hockenberry et al., 1990) .
I Discussion
In the rat, the pancreatic diverticulum originates from the primitive gut on Day 10 of gestation (Slack, 1995; Rutter, 1980; Pictet and Rutter, 1972) . "Protodifferentiated" epithelial cells then appear, which are committed to differentiate into either endocrine or exocrine cells. These protodifferentiated cells have not been well characterized thus far. We found that they express the K20 marker, which we recently reported as a specific marker of mature duct cells , and (c) vimentin. An immature islet containing insulin-positive cells is seen close to a duct (a). Islet cells are positive for K20, although they stain more weakly than the duct cells; also note the larger size of the former. Arrow points to an insulin-positive w e l l that clearly shows . Islet formation starts around Day 17 (Slack, 1995; Rutter, 1980;  Pictet and Rutter, 1972) and is most pronounced during the last days of gestation (Swenne and Eriksson, 1982; McEvoy and Madson, 1980) . It has been postulated that endocrine cells are first formed within the duct lining and then escape to the underlying space to accumulate as islet cells, a process called "budding" (Rutter, 1980; Pictet and Rutter. 1972) . We previously reported that neonatal (immature) islets are surrounded by a mantle of duct cells (Bouwens et al., 1994) . an observation that is difficult to reconcile with the proposed budding mechanism. In the present study of feral islet development, we found that the most prominent morphogenic mechanism was characterized by the formation of large K2O-positive duct cell aggregates. Cells in the center of these aggregates gradually differentiated into hormone-containing cells. During this process, K20 expression decreased in the differentiating islet cells, resulting by the time of birth in a mantle of duct cells around the differentiated, K20-negative islet core. This mechanism of islet morphogenesis from duct cell aggregates. which could be termed "islet-forming units,'' has not been reported thus far. The other mechanism, i.e., small buds detaching from the lining of ducts, appears to be more characteristic for postnatal pancreas when islet neogenesis is induced by partial pancreatectomy (Bonner-Weir et al.. 1993) . duct ligation (Wang et al., 1995) or by transgenic overexpression of interferon-y (Gu and Sarvetnick. 1993 ). Indeed, in a previous study with duct-ligated adult rats, we could not find duct aggregates or islets surrounded by a duct cell mantle, although we found evidence for the neogenesis of islet cells bud-Granular staining is present in cells lining ductules (arrowheads). Bars = 20 pm. ding from the duct lining (Wang et al., 1995) . This indicates that there are two different mechanisms for islet morphogenesis. As a consequence, the islet neogenesis that can be induced in adult animals is not necessarily the "recapitulation" of fetal ontogenesis, as has been proposed by some authors (Bonner-Weir et al., 1993; Gu and Sarvetnick, 1993) .
We found that K20 is a marker for pancreatic stem cells but that it is also expressed in normal adult duct cells . Therefore, our observed transient co-expression of vimentin during islet morphogenesis in duct cells is interesting because it may represent a marker for their morphogenic activity or for "active" stem cells. Vimentin is normally expressed only as an intermediate filament of mesenchymal cells but not in epithelial cells, the intermediate filaments ofwhich are composed of keratins. However, vimentin expression has been found immunohistochemically in some carcinomas and adenomas (Azumi and Battifora. 1987) and in normal epithelium during tissue regeneration after extensive chemical-induced damage in liver (Sarraf et al., 1994) and kidney (Grone et al.. 1987) . In liver regeneration, vimentin occurred in bile ductule and oval cells, which represent putative hepatic stem cells (Sarraf et al.. 1994) . Vimentin is also expressed in epithelial cell lines isolated from adult pancreas and liver. and which represented putative stem cells (Bisgaard and Thorgeimn. 1991) . Vimentin could therefore represent a marker for epithelial stem cell activity during tissue regeneration and, as suggested by our present observations. during fetal development.
Other markers for rat pancreatic stem cells have not been re-ported, with the exception of the glucose transporter Glut-2, which is transiently detected in "endodermal epithelium" between Days 11 and 18 of gestation and thereafter is found only in islet P-cells (Pang et al., 1994) . Another marker that we presently report to be present in pancreatic duct cells is bcl-2. This mitochondrial protooncoprotein is known to protect cells against programmed cell death (Hockenberry et al., 1990) . In epithelial tissues, bcl-2 has been reported to be expressed either in cells that respond to hormonal stimulation by involution or hyperplasia (e.g., thyroid) or in stem cells) (e.g., intestinal crypt cells (Lu et al., 1993) . We presently confirm a previous study on human pancreas in which bcl-2 expression was found to be restricted to the duct epithelium (Lu et al., 1993) . In the liver, bcl-2 was confined to biliary duct cells, which are considered as putative liver stem cells (Charlotte et al., 1994) . Taken together, the bcl-2 expression in rat fetal and adult duct cells further suggests that these are pancreatic stem cells. Because all duct cells contained bcl-2, the possibility remains that they all are potential stem cells.
